Targeting of perfluorocarbon microbubbles to selective populations of circulating blood cells

Dmitri Simberg, Robert Mattrey

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Perfluorocarbon microbubbles (MBs) are routinely used as in vivo ultrasound contrast reagent. In addition, there is great interest in the use of MBs for ultrasound-mediated delivery, for example, of drugs and genes. As MB size (110 μm) limits their distribution to the vasculature, we aimed to assess the efficiency of targeting MBs to circulating cells using antibodies. Our experiments showed that MBs efficiently bind to erythrocytes and B-lymphoma cells in blood. The maximum binding was reached at a cell/MB ratio of 1:1. Following binding, the cells acquired buoyancy that allowed their easy separation from blood with brief centrifugation. Coating the MBs with DNA did not interfere with binding to cells. Experiments in mice showed that intravenously injected targeted MBs efficiently chased and bound to preinjected target cells in the bloodstream. Our data demonstrate the potential in targeting of blood cells for diagnostics and therapy.

Original languageEnglish (US)
Pages (from-to)392-398
Number of pages7
JournalJournal of Drug Targeting
Volume17
Issue number5
DOIs
StatePublished - Jun 1 2009

Fingerprint

Fluorocarbons
Microbubbles
Blood Cells
Population
B-Cell Lymphoma
Cell- and Tissue-Based Therapy
Centrifugation
Erythrocytes
Antibodies
DNA

Keywords

  • Blood
  • Lymphoma
  • Microbubbles
  • Rituximab
  • Targeting
  • Ultrasound

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Targeting of perfluorocarbon microbubbles to selective populations of circulating blood cells. / Simberg, Dmitri; Mattrey, Robert.

In: Journal of Drug Targeting, Vol. 17, No. 5, 01.06.2009, p. 392-398.

Research output: Contribution to journalArticle

@article{f77dc1183f544f53b9888898e7cf7dcb,
title = "Targeting of perfluorocarbon microbubbles to selective populations of circulating blood cells",
abstract = "Perfluorocarbon microbubbles (MBs) are routinely used as in vivo ultrasound contrast reagent. In addition, there is great interest in the use of MBs for ultrasound-mediated delivery, for example, of drugs and genes. As MB size (110 μm) limits their distribution to the vasculature, we aimed to assess the efficiency of targeting MBs to circulating cells using antibodies. Our experiments showed that MBs efficiently bind to erythrocytes and B-lymphoma cells in blood. The maximum binding was reached at a cell/MB ratio of 1:1. Following binding, the cells acquired buoyancy that allowed their easy separation from blood with brief centrifugation. Coating the MBs with DNA did not interfere with binding to cells. Experiments in mice showed that intravenously injected targeted MBs efficiently chased and bound to preinjected target cells in the bloodstream. Our data demonstrate the potential in targeting of blood cells for diagnostics and therapy.",
keywords = "Blood, Lymphoma, Microbubbles, Rituximab, Targeting, Ultrasound",
author = "Dmitri Simberg and Robert Mattrey",
year = "2009",
month = "6",
day = "1",
doi = "10.1080/10611860902902797",
language = "English (US)",
volume = "17",
pages = "392--398",
journal = "Journal of Drug Targeting",
issn = "1061-186X",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Targeting of perfluorocarbon microbubbles to selective populations of circulating blood cells

AU - Simberg, Dmitri

AU - Mattrey, Robert

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Perfluorocarbon microbubbles (MBs) are routinely used as in vivo ultrasound contrast reagent. In addition, there is great interest in the use of MBs for ultrasound-mediated delivery, for example, of drugs and genes. As MB size (110 μm) limits their distribution to the vasculature, we aimed to assess the efficiency of targeting MBs to circulating cells using antibodies. Our experiments showed that MBs efficiently bind to erythrocytes and B-lymphoma cells in blood. The maximum binding was reached at a cell/MB ratio of 1:1. Following binding, the cells acquired buoyancy that allowed their easy separation from blood with brief centrifugation. Coating the MBs with DNA did not interfere with binding to cells. Experiments in mice showed that intravenously injected targeted MBs efficiently chased and bound to preinjected target cells in the bloodstream. Our data demonstrate the potential in targeting of blood cells for diagnostics and therapy.

AB - Perfluorocarbon microbubbles (MBs) are routinely used as in vivo ultrasound contrast reagent. In addition, there is great interest in the use of MBs for ultrasound-mediated delivery, for example, of drugs and genes. As MB size (110 μm) limits their distribution to the vasculature, we aimed to assess the efficiency of targeting MBs to circulating cells using antibodies. Our experiments showed that MBs efficiently bind to erythrocytes and B-lymphoma cells in blood. The maximum binding was reached at a cell/MB ratio of 1:1. Following binding, the cells acquired buoyancy that allowed their easy separation from blood with brief centrifugation. Coating the MBs with DNA did not interfere with binding to cells. Experiments in mice showed that intravenously injected targeted MBs efficiently chased and bound to preinjected target cells in the bloodstream. Our data demonstrate the potential in targeting of blood cells for diagnostics and therapy.

KW - Blood

KW - Lymphoma

KW - Microbubbles

KW - Rituximab

KW - Targeting

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=69149107303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69149107303&partnerID=8YFLogxK

U2 - 10.1080/10611860902902797

DO - 10.1080/10611860902902797

M3 - Article

C2 - 19505207

AN - SCOPUS:69149107303

VL - 17

SP - 392

EP - 398

JO - Journal of Drug Targeting

JF - Journal of Drug Targeting

SN - 1061-186X

IS - 5

ER -